Navigation Links
Bethesda-Based NHSi Wins $2M Grant for Blood Technology

BETHESDA, Md., May 26 /PRNewswire/ -- New Health Sciences Inc. (NHSi) has won a two-year award of $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a groundbreaking blood-storage system.

The project aims to develop the Hemanext Anaerobic Storage Platform, which delivers higher quality blood for transfusion therapy and extends the shelf life of blood for transfusion.

NHSi has demonstrated that this new technology can deliver higher-quality, more physiologic blood, with an improved capacity to deliver oxygen and more deformable red blood cells for better capillary perfusion, and extend by 50 percent or more the shelf life of stored red blood cells.

The Small Business Innovation Research Phase II grant from NIH, announced March 27, follows a 2007-2008 Phase I grant of $133,290.

"This grant is a major step forward for transfusion medicine," NHSi President Martin Cannon said. "Evidence is mounting that, following transfusions, patients experience a multitude of complications resulting in increased morbidity and longer hospital stays that might have been prevented had better stored, better transported, and better preserved blood been used."

"Our technology aims to address this problem and in doing so, reduce the human and economic costs associated with extended hospitalization," Cannon said.

Research has documented that the rate of complications increases with the number of units of blood transfused. Moreover, in a relatively large study, significantly worse post-operative outcomes were associated with blood stored longer than 15 days.

NHSi expects widespread adoption of its Hemanext Anaerobic Storage Platform will reduce the adverse side effects of life-saving blood transfusions and streamline blood-bank operations -- alleviating periodic blood shortages and increasing pre-operative autologous (self-donated) blood donations.

"This research represents a paradigm shift in the approach to storage of red cells, the most significant change since the introduction of additive solutions 25 years ago," Professor James AuBuchon of the University of Washington and President & CEO of Puget Sound Blood Center, said.

"As concern mounts about the clinical impact of storage time of red cell units, reduction in the storage lesion that accumulates has taken on increased importance. Anaerobic storage is a new tool that may not only lengthen but improve the storage of these life-saving cells," AuBuchon said.

NHSi's Director of Research and Development Dr. Tatsuro Yoshida said the new NIH grant "will enable us to move this laboratory technology to everyday use at blood banks by developing an inexpensive, self-contained storage system easily accommodated under current blood-bank operations."

The Medical Device Laboratory, McGowan Institute for Regenerative Medicine at University of Pittsburgh (Professor William Federspiel), Filtertek Inc. of Hebron, Illinois, and Multisorb Technologies of Buffalo, New York, will help develop this new technology.

The clinical trial will be conducted in the laboratory of Dr. Larry J. Dumont at Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire.

In conjunction with this advanced blood storage technology, NHSi is also developing a microchip-based diagnostic device to evaluate the quality of red blood cells stored for transfusion.

Red blood cells' diminished capacity to deform and perfuse narrow capillary networks in tissues is believed to be a major cause of transfusion side effects. Before dispensing a unit of blood to the patient, the NHSi device evaluates the "fitness" of stored red blood cells by passing it through an artificial capillary network produced on a disposable microchip. This work is currently carried out in a partnership with Tulane University.

About New Health Sciences:

NHSi is a privately held company that is developing and commercializing two, strategically linked technologies. The first, Hemodyanamic Vascular Analysis ("HVA"), is a proprietary software and data-based diagnostic and disease management platform. HVA addresses a large and growing need in neurovascular medicine for more precise, inexpensive and safe diagnostic and disease management tools. The second, Hemanext, is novel technology to deliver red blood cells (RBCs) of higher efficacy for transfusion therapy, and at the same time, extend the shelf life of refrigerated RBCs. For more information on the company and other developments, visit

    Martin Cannon (301) 493-4586 or Barret Hildebrand (301) 493-4562
    6303 Rockledge Drive, Suite 230
    Bethesda, MD 20817-1818

SOURCE New Health Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Chinese SFDA Grants Immtech Fast Track Status
6. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
9. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
10. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
(Date:10/8/2015)... Oct. 9, 2015 Johnson & Johnson (NYSE: ... immunogenicity clinical trial in Sierra Leone ... Janssen Pharmaceutical Companies. Trial recruitment is underway, and the first ... first study conducted of Janssen,s Ebola prime-boost vaccine regimen in ... Sierra Leone,s Kambia district, where ...
(Date:10/8/2015)...  Ardelyx, Inc. (NASDAQ: ARDX ), a ... diseases, today announced that clinical data for the ... at the 2015 American College of Gastroenterology (ACG) ... sustained response in IBS-C patients enrolled in the ... trial. The meeting will be held in ...
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... cell-free molecular diagnostics, today announced the presentation of ... use of its Precision Cancer Monitoring SM ... can be critical for physicians to determine appropriate ... chief scientific officer of Trovagene is delivering the ...
Breaking Medicine Technology:
... February is American Heart Month and a time when ... on their family history of heart disease and recommit ... teaming up with the makers of Bayer® Aspirin and ... to raise $100,000 for the fight against heart disease. ...
... 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Leerink Swann 2012 Global Healthcare Conference to be ... New York City.  Mr. Adrian Adams, Chief Executive Officer ... the Company and its product pipeline at 10:30 a.m. ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... Well-known Eastern ... to be recognized by The National Law Journal for inclusion in their second ... firms across the United States who obtained the largest awards for their personal ...
(Date:10/9/2015)... California (PRWEB) , ... October 09, 2015 , ... ... Osteopathic Medicine of the Pacific Associate Dean for Graduate Medical Education J. Michael ... of the Year Award. Finley was selected for his impact on graduate medical ...
(Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack from ... A LUT is a Lookup Table that contains a mathematical formula for modifying an ... table. This pack comes with 60 vibrant CUBE LUT files. , Inspired ...
(Date:10/9/2015)... ... October 09, 2015 , ... Smoke alarms can save lives. In fact, ... risk of dying in reported home fires in half. As part of Fire Prevention ... are property installed and maintained. , Half of home fire deaths result from fires ...
(Date:10/9/2015)... ... , ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend the ... in Huntsville, Texas on October 17-21. , "It's very exciting to be invited ... executive director, said. “It's a stepping stone into the U.S. elite system where Maddie ...
Breaking Medicine News(10 mins):
... Neuroscientists at MIT,s Picower Institute of Learning and Memory have ... inexplicably linked to long-term memories. The work is slated to ... "Our finding explains, at least partially, why seemingly irrelevant ... person is remembered as vividly as more significant information such ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay News) -- This winter ... instead is turning out to be a more typical flu season, ... to get a flu shot, advice that seniors in particular should ... their age group the hardest, the experts added. The H1N1 flu ...
... for Injury Biomechanics ( ) has been awarded ... Research and Materiel Command for phase 2 of an ... military personnel. Specifically, blast induced brain trauma will be ... helmet design and body armor and the resulting reductions ...
... Liverpool-led consortium has received $1.5million from the Bill & ... serious disease and epidemics in sub-Saharan Africa. Streptococcus ... in sub-Sahara Africa. The funding will enable scientists ... associated with invasive pneumococcal disease, why it spreads so ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay ... by patients and health professionals alike to save money ... and potentially dangerous, a new study suggests. Belgian ... deviated from recommended dosages by 15 percent or more. ...
... HealthDay Reporter , WEDNESDAY, Jan. 12 (HealthDay News) -- ... said Tuesday, breathing on her own and moving both arms ... "She has a 101 percent chance of surviving," Dr. ... told the Associated Press . "She will not die." ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: